Fair Pay & Worker Respect

MacroGenics explicitly states that its employees are not subject to a collective bargaining agreement or represented by a trade or labor union, indicating 0% collective bargaining coverage.

An employee engagement survey conducted in December 2022, with 87% participation, reported an 84% favorable response to "I am proud to work for MacroGenics and feel a meaningful connection." The company also reported a 95% participation rate in its 2024 employee engagement survey.

Fair Trade & Ethical Sourcing

No specific quantitative data for MacroGenics, Inc. (MGNX.US) related to fair trade and ethical sourcing was found in the provided articles.

The articles either explicitly state a lack of relevant quantitative data for MGNX.US or provide general industry averages that cannot be attributed to the company. Therefore, no KPIs under this value can be scored.

Kind to Animals

MacroGenics conducts preclinical trials on animals for its medical products and clinical research, including repeat-dose non-human primate toxicology studies.

The company states a commitment to the '3Rs' (Replacement, Reduction, and Refinement) in animal research , and its supplier code of conduct mandates humane treatment and efforts to minimize pain and stress. However, it explicitly utilizes animal models where suitable non-animal alternatives are not available, indicating a reliance on traditional animal assays. The company reports using 25,000-50,000 animals annually for testing, with no transparent reduction targets mentioned. All animal care and technical procedures are carried out by trained staff/vendors under the oversight of an Institutional Animal Care and Use Committee (IACUC) and must comply with federal regulations, including the Animal Welfare Act.

No War, No Weapons

MacroGenics is a biopharmaceutical company focused on cancer treatments, and its revenue streams are derived from collaborative agreements, product sales, and contract manufacturing of pharmaceuticals.

The company does not have any revenue from arms or defense contracts, nor does it develop or sell dual-use technologies with military applications. The company's Code of Business Conduct and Ethics states that it complies with U.S. economic sanctions and trade embargoes, and will not engage in dealings with sanctioned countries without legal department approval. The Board of Directors oversees the management of the company's business, but there is no specific mention of oversight over defense-related activities, as these are not part of the company's core business. The company sponsors students at Don Bosco Cristo Rey, a school for students from families with limited economic means, since 2021, but the proportion of revenue allocated to this initiative is not specified. All MacroGenics personnel are required to adhere to the Code of Business Conduct and Ethics, for which they receive training annually. The Board of Directors sets high standards for the company's employees, officers, and directors, but there is no explicit mention of alignment with UN Guiding Principles on Business and Human Rights.

Planet-Friendly Business

MacroGenics, Inc. has not provided specific quantitative data for any of the Planet-Friendly Business KPIs in the available articles. While the company's 2023 Corporate Responsibility Report mentions environmental responsibility initiatives such as waste management and energy efficiency measures (e.g., LED lighting, low-flow restroom fixtures, waste segregation for recyclables), it does not include specific metrics like total greenhouse gas emissions, percentage of renewable energy used, water use per revenue, or waste diversion rates.

The company states it complies with Federal and State environmental regulations and maintains a Waste Management Plan, but no data on compliance violations or environmental impact assessments is provided. ESG risk ratings from Sustainalytics are mentioned, but these do not contain the specific environmental performance data required by the rubric.

Respect for Cultures & Communities

The provided articles focus on MacroGenics' biopharmaceutical activities and general biotechnology industry news. They do not contain any specific data or information regarding the company's community engagement practices, cultural sensitivity, or social responsibility initiatives relevant to the 'Respect for Cultures & Communities' value.

Therefore, no KPIs can be scored based on the evidence provided.

Safe & Smart Tech

MacroGenics reported no material cybersecurity breaches in 2023.

All company personnel are required to receive annual training on the Code of Business Conduct and Ethics, which includes cybersecurity risks, and receive continuous education and training on cybersecurity risks and mitigation procedures. The company states it retains data only as long as reasonably required for legal, contractual, or business purposes. MacroGenics' privacy policies address compliance with various regulations, including the California Consumer Privacy Act (CCPA), Washington My Health My Data Act, Nevada State Consumer Health Privacy Law, and Connecticut consumer health data rights. For Washington and Nevada residents, users have rights to confirm, access, copy, delete, and withdraw consent for their data, with an appeals process available.